Esperion Therapeutics, Inc.
GB ˙ LSE ˙ US29664W1053
3,13 USD ↓ -0,00 (-0,16%)
2026-06-05
PREZZO DELLE AZIONI
SecurityGB:0IIM / Esperion Therapeutics, Inc.
InstitutionMan Group plc
Latest Disclosed Ownership339,775 shares
Latest Disclosed Value $ 930,984
Man Group plc ownership in 0IIM / Esperion Therapeutics, Inc.

On May 15, 2026 - Man Group plc filed a 13F-HR form disclosing ownership of 339,775 shares of Esperion Therapeutics, Inc. (GB:0IIM) valued at $923,542 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 14, 2025 disclosing 0 shares of Esperion Therapeutics, Inc.. The current value of the position is $1,063,496 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 339,775 339,775 931 0.0010
2025-02-14 2024-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -25,692 -100.00 0 -100.00
2024-11-14 2024-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 25,692 25,692 42 0.0001
2024-08-14 2024-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -440,770 -100.00 0 -100.00
2024-05-15 2024-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 440,770 223,785 103.13 1,181 82.25 0.0030
2024-02-14 2023-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 216,985 649 1,250.00 0.0018
2023-11-14 2023-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 48 -70.37 0.0002
2023-08-14 2023-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 117,251 163 43.36 0.0005
2023-05-15 2023-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 114 0.89 0.0004
2023-02-14 2022-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 18,100 113 -62.67 0.0004
2022-08-15 2022-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 300 -42.75 0.0013
2022-05-16 2022-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 112,903 112,903 524 0.0018
2022-02-14 2021-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -15,756 -100.00 0 -100.00
2021-11-15 2021-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 15,756 1,978 14.36 190 -34.71 0.0007
2021-08-16 2021-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 13,778 -14,248 -50.84 291 -62.98 0.0010
2021-05-17 2021-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 28,026 -9,554 -25.42 786 -19.55 0.0035
2021-02-16 2020-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 37,580 19,969 113.39 977 49.16 0.0043
2020-11-16 2020-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 17,611 281 1.62 655 -26.32 0.0026
2020-08-14 2020-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 17,330 10,992 173.43 889 344.50 0.0045
2020-05-15 2020-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 6,338 -276,658 -97.76 200 -98.81 0.0013
2020-02-18 2019-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 282,996 76,369 36.96 16,875 122.77 0.0555
2019-11-14 2019-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 206,627 -52,056 -20.12 7,575 -37.05 0.0281
2019-08-14 2019-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 258,683 24,566 10.49 12,034 28.03 0.0435
2019-05-15 2019-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 234,117 70,331 42.94 9,399 24.74 0.0357
2019-02-14 2018-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 163,786 20,218 14.08 7,535 18.29 0.0335
2018-11-14 2018-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 143,568 120,357 518.53 6,370 600.00 0.0233
2018-08-14 2018-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 23,211 23,211 910 0.0037
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.